Filing Details
- Accession Number:
- 0001493152-21-024640
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-05 17:00:20
- Reporting Period:
- 2021-10-01
- Accepted Time:
- 2021-10-05 17:00:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1833214 | Big Cypress Acquisition Corp. | BCYP | Biological Products, (No Disgnostic Substances) (2836) | 853899721 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1838085 | Ilan Katz | C/O Big Cypress Acquisition Corp. 300 W. 41St Street, Suite 202 Miami Beach FL 33140 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-01 | 1,000 | $10.09 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,047,825 | Indirect | See Footnote |
Footnotes
- Represents 1,000 shares of the issuer's common stock acquired by the reporting person in open market transactions.
- Includes 3,047,825 shares of the issuer's common stock held directly by Big Cypress Holdings LLC (the "Sponsor") and indirectly by Samuel J. Reich and Ilan Katz as managers of the Sponsor, which includes 417,200 private placement units of the issuer. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of common stock of the issuer and one-half of one warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering.